Spire Wealth Management Novavax Inc Transaction History

Spire Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$36.28 - $75.29 $2,721 - $5,646	-75 Reduced 44.12%	95 $5,000
Q1 2022 Apr 18, 2022	SELL	$69.73 - $142.9 $139 - $285	-2 Reduced 1.16%	170 $13,000
Q4 2021 Jan 14, 2022	BUY	$134.56 - $217.97 $15,070 - $24,412	112 Added 186.67%	172 $25,000
Q2 2021 Jul 26, 2021	BUY	$121.0 - $257.67 $4,840 - $10,306	40 Added 200.0%	60 $13,000
Q1 2021 May 21, 2021	BUY	$112.98 - $319.93 $2,259 - $6,398	20 New	20 $4,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.